Genzyme Corporation Restates Results, Discards More Drugs

NEW YORK Aug 9 (Reuters) - Genzyme Corp (GENZ.O) on Monday said it was restating quarterly results to account for additional inventories of drugs it has had to discard for failure to meet the company's quality standards.